Neurocrine Bioscienc (NQ: NBIX )
127.06
-1.37
(-1.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Headline News about Neurocrine Bioscienc![]()
Analyst Views Karuna Therapeutics' New Licensing Deal 'As Intriguing'
February 03, 2023
Via Benzinga
![]() ![]() ![]() ![]()
Neurocrine Biosciences Buys UK-Based Hormone Therapy Player
August 30, 2022
Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Via Benzinga
![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022
September 26, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|